Journal News

Which eight escaped the Scientific 16?

JBC Methods Madness: Round 1 recap
Anand Rao
March 22, 2021

The Journal of Biological Chemistry’s Methods Madness tournament started off with a bang as last year’s finalist, #TeamMassSpec, faced off against the tournament newcomer #TeamFRET. #TeamFRET fought valiantly, but their supporters’ energy just didn’t transfer into votes. Meanwhile, #TeamMassSpec supporters turned up in SPECTRAcular numbers, pushing their team to the next round.

X-ray crystallographers around the world are rejoicing after #TeamXRC’s victory over #TeamImmuno. Votes proved to be too nonspecific for #TeamImmuno, whose supporters were unable to band together to provide support for their team. #TeamXRC advances to the next round while #TeamImmuno fades into the background.

#TeamCryo iced their competition, leaving #TeamMachine frozen in their tracks. Despite strategic support from #TeamMassSpec, it seems too many #TeamMachine supporters had their heads in the cloud, because they couldn’t find the algorithm needed to execute a win against the defending champion. #TeamCryo will move on to the Energetic Eight, where they will have a tough matchup against #TeamCRISPR.

In this cellular showdown, #TeamiPSC lacked the factors necessary to differentiate from the other losers of the week. In contrast, #TeamLiveCell was unphased by the pressure, shining bright in the win they captured. #TeamLiveCell has #TeamOmics in their frame as they focus on the next round.

#TeamPCR copied last year’s success to defeat #TeamChroma and advance to the next round. Supporters of #TeamChroma couldn’t match the flow rate of #TeamPCR voters, leaving #TeamChroma stuck in a stationary phase while their opponent mobilized. #TeamPCR will look to amplify their success with a win over #TeamMassSpec in the next round.

Resonating with their supporters, #TeamNMR put forth a dynamic performance to secure their second #JBCMethodsMadness win in as many years. Living up to their name, #TeamCloning replicated last year’s performance where they also lost against #TeamNMR in the first round. Perhaps they’ll find the winning recombination next year!

#TeamCRISPR excised #TeamSuperRes in the first round of the tournament and will move on to the next round. Despite their resolution to make it further this year, the win that #TeamSuperRes pictured was never fully deconvolved. #TeamCRISPR has their work cut out for them, facing off against the defending champion #TeamCryo.

Seq-ing a win in their tournament debut, #TeamOmics analyzed their competition and came out victorious. Seemingly unable to shed light on a winning formula, #TeamOpto failed to excite their supporters, resulting in their second tournament loss in as many years. Next, #TeamOmics will match up against #TeamLiveCell in the Energetic Eight round.

Round 2: The Energetic Eight

Monday, March 22

12 p.m. Eastern – #TeamNMR vs. #TeamXRC

Tuesday, March 23

12 p.m. Eastern – #TeamPCR vs. #TeamMassSpec

Wednesday, March 24

12 p.m. – #TeamLiveCell vs. #TeamOmics

Thursday, March 25

12 p.m. – #TeamCryo vs. #TeamCRISPR

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anand Rao

Anand Rao is the former ASBMB publications strategy manager.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.

How copper delivery fuels bacterial respiration
Journal News

How copper delivery fuels bacterial respiration

April 1, 2026

Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.

Revealing the glycoproteome of a cancer subtype
Journal News

Revealing the glycoproteome of a cancer subtype

March 31, 2026

Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.